
Diego A. Díaz-García/X
Aug 9, 2025, 17:36
Diego Díaz-García: Targeted Protein Degradation is Reshaping Cancer Therapy
Diego A. Díaz-García, Medical Oncologist, CEO, and Founder of CánCare – Advanced Oncology Specialty, shared a post on X about a paper by Matthias Hinterndorfer et al. published on the Nature Reviews Cancer:
“Targeted protein degradation is reshaping cancer therapy:
From PROTACs to molecular glues, new tools are enabling selective elimination of oncogenic proteins, with clinical impact on the horizon.”
Title: Targeted protein degradation for cancer therapy
Authors: Matthias Hinterndorfer, Valentina Spiteri, Alessio Ciulli, Georg Winter
You can read the Full Article on the Nature Reviews Cancer.
More posts featuring Cancer Therapy on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 9, 2025, 17:12
Aug 9, 2025, 17:05
Aug 9, 2025, 16:39
Aug 9, 2025, 16:33
Aug 9, 2025, 16:14
Aug 9, 2025, 16:13